Comparison the cumulative incidence of relapse (CIR) between the T-ALL patients with low and high TEL1 gene expressions revealed that the CIR was significantly higher subgroup of T-ALL patients with low TEL1 expression as compared to those with high TEL1 expression (P=0.024) (Figure 3). This evidence concerns the gene ETV6 and acute lymphoblastic leukemia.